February 20, 2026

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 14.7% Revenue Growth Amidst Valuation Challenges

InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, particularly within the medical care facilities industry, is making waves with a notable 14.7%..

Talkspace, Inc. (TALK) Stock Analysis: Robust Revenue Growth and Analyst Optimism Signal Investment Potential

Talkspace, Inc. (NASDAQ: TALK), a prominent player in the Health Information Services industry, has been making waves in the virtual behavioral healthcare sector. With a market..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: A Biotech with 120% Upside Potential

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is capturing the attention of investors with a compelling growth narrative and a significant potential upside of 120.66%. Headquartered in Cambridge,..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a Potential 141% Upside in the Healthcare Sector

Nutex Health Inc. (NUTX), a key player in the healthcare sector specializing in medical care facilities, is capturing the attention of investors with its compelling growth..

AxoGen, Inc. (AXGN): Growth Potential in the Healthcare Sector with a Promising 7.40% Upside

AxoGen, Inc. (NASDAQ: AXGN), a notable player in the healthcare sector, is making waves within the medical devices industry. With a market capitalization of $1.76 billion,..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Unveiling a 110% Potential Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the healthcare sector, has been capturing the interest of investors with its innovative approach to cell-based therapies...

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Amidst a 27.10% Potential Upside

STAAR Surgical Company (NASDAQ: STAA), a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry, has captured the attention of investors..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: 44.68% Potential Upside Amidst Innovative Diagnostics Growth

Fulgent Genetics, Inc. (NASDAQ: FLGT) stands at an intriguing juncture for investors, particularly those with an appetite for innovation-driven growth in the healthcare sector. Operating primarily..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Unpacking a 129.65% Potential Upside

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its focus on innovative gene therapies for..

Owens & Minor, Inc. (OMI) Stock Analysis: Is Nearly 94% Upside Within Reach?

For investors seeking opportunities in the healthcare sector, Owens & Minor, Inc. (NYSE: OMI) presents a compelling case. The company, a long-standing player in the medical..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: 82.95% Potential Upside Captures Investor Attention

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering force in the biotechnology sector, is drawing investor interest with a striking potential upside of 82.95%. As a clinical-stage..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Investors Eye 113.97% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is garnering attention from investors with its promising pipeline in the biotechnology sector, notably targeting diseases with unmet needs. As a..

Ardelyx, Inc. (ARDX) Stock Analysis: A Biotech Gem with 118% Upside Potential

Ardelyx, Inc. (NASDAQ: ARDX) is a prominent player in the biotechnology sector, specifically targeting unmet medical needs through innovative therapies. With a market capitalization of $1.64..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring Growth Potential Amid a 4.91% Upside

Enhabit, Inc. (EHAB), a prominent player in the healthcare sector, operates within the medical care facilities industry, offering essential home health and hospice services across the..

Valneva SE (VALN) Stock Analysis: A Vaccine Innovator with a 21% Upside Potential

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in the development and commercialization of vaccines, is making significant strides in the healthcare industry. Despite its..

NeuroPace, Inc. (NPCE) Stock Analysis: Exploring the 34.58% Potential Upside with Strong Buy Ratings

Investors looking to capitalize on growth within the healthcare sector should turn their attention to NeuroPace, Inc. (NASDAQ: NPCE), a prominent player in the medical devices..

Dianthus Therapeutics, Inc. (DNTH): Analyst Consensus Points to a Promising 46.82% Upside Potential

Dianthus Therapeutics, Inc. (DNTH) is emerging as a notable player in the biotechnology sector, captivating the attention of individual investors with its potential to offer significant..

Auna SA (AUNA) Stock Analysis: Investor Outlook with a 42.86% Potential Upside

Auna SA (AUNA), a Luxembourg-based healthcare service provider, is positioned uniquely within the medical care facilities industry. With operations spanning across Mexico, Peru, and Colombia, Auna..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating a Challenging Market with a 20.7% Upside Potential

AMN Healthcare Services Inc (AMN), a prominent player in the healthcare sector, particularly within the medical care facilities industry, presents a compelling case for investors looking..

Search

Funds

February 20, 2026

Search

Funds

February 20, 2026

FTSE 100

Funds